Search

everythinglearnresearchcommunity

for

Search:↓

An elderly woman's upper lip lump, thought to be a mucocele, was actually a rare type of lymphoma usually found on legs, treated successfully with chemotherapy and radiation.

Targeted immunological therapies offer safer and more effective treatments for skin conditions like eczema and psoriasis.

Pulsed dye laser treatment was effective for a skin condition resistant to other treatments.

Some cells may slow melanoma growth, a protein could affect skin pigmentation, a gene-silencing method might treat hair defects, skin bacteria changes likely result from eczema, and a defensin protein could help treat multiple sclerosis.

Early use of infliximab in severe pediatric Crohn's disease can lead to significant improvement and remission.

Teriflunomide effectively reduces relapse rates and disease progression in multiple sclerosis but is not safe for use during pregnancy.

Ustekinumab treatment didn't prevent frontal fibrosing alopecia.

Combining hydroxychloroquine and pimecrolimus can effectively treat hair loss from discoid lupus.

Gemcitabine and Disitamab Vedotin effectively and safely reduced bladder cancer in a patient.

Denosumab, a bone loss treatment, may cause hair loss and skin reactions due to immune system effects.

A new skin disease in four Labrador retrievers responded well to immunosuppressive treatment.

Tofacitinib may be safe and effective for treating certain skin conditions in children.

Pioglitazone use was linked to hair regrowth in a patient with permanent hair loss from cicatricial alopecia.

The combination treatment showed a higher response rate but no significant survival benefits.

Long-term Imiquimod treatment causes initial skin inflammation that lessens over time, and topical corticosteroids reduce this inflammation and cytokines in a mouse model of psoriasis.

Tofacitinib helped psoriasis but not alopecia universalis, needing more research.

A woman with IgG/IgA pemphigus was treated successfully with dapsone and steroids.

Ruxolitinib helped a woman with a genetic mutation regrow her hair and improved her health.

JAK inhibitors improve hair growth in alopecia areata, especially in patchy types.

ARQ-234, a protein designed to treat atopic dermatitis, shows increased effectiveness in early testing.

Ritlecitinib can help about 14,000 people with severe hair loss.

Targeting multiple pathways and understanding genetic mutations are crucial for effective melanoma therapy.

Abrocitinib may help treat alopecia areata effectively with mild side effects.

Blocking IL-12 can help treat alopecia areata by preventing hair follicle immune issues.

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

PPAR-γ agonists like pioglitazone may help manage lichen planopilaris but don't fully reverse scarring.

Lenalidomide helps hair follicle stem cells turn into melanocytes, which may improve repigmentation in vitiligo.

Eribulin-based chemotherapy is more effective and has fewer side effects for advanced triple-negative breast cancer.

Tofacitinib successfully treated a woman's severe symptoms from a rare autoimmune condition.